WIXOM,
Mich., May 11, 2022 /PRNewswire/ -- Rockwell
Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated
to transforming the treatment of iron deficiency and anemia
management and improving outcomes for patients around the world,
today announced that it will host a conference call on Monday, May 16 at 4:15 PM
ET to discuss its financial results for the three months
ended March 31, 2022, and recent
operational highlights.
To access the conference call, please dial (877) 383-7438
(local) or (678) 894-3975 (international) at least 10 minutes
prior to the start time and refer to conference ID 2599375. A live
webcast of the call will be available under "Events &
Presentations" in the Investor section of the Company's website,
https://ir.rockwellmed.com/. An archived webcast will be available
on the Company's website approximately two hours after the event
and will be available for 30 days.
To submit questions in advance, please email your questions to
invest@rockwellmed.com.
About Rockwell Medical
Rockwell Medical is a commercial-stage biopharmaceutical
company developing and commercializing its next-generation
parenteral iron technology platform, Ferric Pyrophosphate Citrate
(FPC), which has the potential to lead transformative treatments
for iron deficiency in multiple disease states, reduce healthcare
costs and improve patients' lives. The Company has two FDA-approved
therapies indicated for patients undergoing hemodialysis, which are
the first two products developed from the FPC
platform. Rockwell Medical is also advancing its FPC
platform by developing FPC for the treatment of iron deficiency
anemia in patients outside of dialysis, who are receiving
intravenous medications in the home infusion setting. In
addition, Rockwell Medical is one of two major suppliers
of life-saving hemodialysis concentrate products to kidney dialysis
clinics in the United States. For more information,
visit www.RockwellMed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rockwell-medical-inc-to-report-first-quarter-2022-financial-and-operating-results-on-may-16-2022-301544919.html
SOURCE Rockwell Medical Technologies, Inc.